HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-steroidal anti-inflammatory drugs increase insulin release from beta cells by inhibiting ATP-sensitive potassium channels.

AbstractBACKGROUND AND PURPOSE:
Some non-steroidal anti-inflammatory drugs (NSAIDs) incidentally induce hypoglycemia, which is often seen in diabetic patients receiving sulphonylureas. NSAIDs influence various ion channel activities, thus they may cause hypoglycemia by affecting ion channel functions in insulin secreting beta cells. This study investigated the effects of the NSAID meclofenamic acid (MFA) on the electrical excitability and the secretion of insulin from pancreatic beta cells.
EXPERIMENTAL APPROACH:
Using patch clamp techniques and insulin secretion assays, the effects of MFA on the membrane potential and transmembrane current of INS-1 cells, and insulin secretion were studied.
KEY RESULTS:
Under perforated patch recordings, MFA induced a rapid depolarization in INS-1 cells bathed in low (2.8 mM), but not high (28 mM) glucose solutions. MFA, as well as acetylsalicylic acid (ASA) and flufenamic acid (FFA), excited the cells by inhibiting ATP-sensitive potassium channels (K(ATP)). In whole cell recordings, K(ATP) conductance consistently appeared when intracellular ATP was diluted. Intracellular glibenclamide prevented the development of K(ATP) activity, whereas intracellular MFA had no effect. At low glibenclamide concentrations, MFA induced additional inhibition of the K(ATP) current. Live cell Ca(2+) imaging displayed that MFA elevated intracellular Ca(2+) at low glucose concentrations. Furthermore, MFA dose-dependently increased insulin release under low, but not high, glucose conditions.
CONCLUSIONS AND IMPLICATIONS:
MFA blocked K(ATP) through an extracellular mechanism and thus increased insulin secretion. As some NSAIDs synergistically inhibit K(ATP) activity together with sulphonylureas, the risk of NSAID-induced hypoglycemia should be considered when glucose-lowering compounds are administered.
AuthorsJ Li, N Zhang, B Ye, W Ju, B Orser, J E M Fox, M B Wheeler, Q Wang, W-Y Lu
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 151 Issue 4 Pg. 483-93 (Jun 2007) ISSN: 0007-1188 [Print] England
PMID17435793 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Insulin
  • Potassium Channel Blockers
  • Meclofenamic Acid
  • Adenosine Triphosphate
  • Glucose
  • Calcium
Topics
  • Adenosine Triphosphate (pharmacology)
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Calcium (metabolism)
  • Cells, Cultured
  • Glucose (pharmacology)
  • Insulin (metabolism)
  • Insulin Secretion
  • Insulin-Secreting Cells (drug effects, metabolism, physiology)
  • Meclofenamic Acid (pharmacology)
  • Membrane Potentials (drug effects)
  • Mice
  • Potassium Channel Blockers (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: